Hong AR, Lee J, Ku EJ et al (2015) Comparison of vildagliptin as an add-on therapy and sulfonylurea dose-increasing therapy in patients with inadequately controlled type 2 diabetes using metformin and sulfonylurea (VISUAL study): a randomized trial
Today, were taking a pivotal step forward in addressing some of the most pressing health issues of our time with the added indication for Wegovy, said Doug Langa, executive vice president, head of North America operations, and president of Novo Nordisk
In light of this data, your provider may suggest a plan for lowering your dosage of semaglutide slowly, such as stepping down the dose every few weeks or months
This section explains the type of progress most adults see, how quickly changes occur, and what improvements you can anticipate as the SYNERGY RX GLP1 treatment becomes part of your weekly routine
At steady state, the amount of drug being administered each week equals the amount being eliminated, creating a stable concentration